Annual EBIT
-$20.60 M
+$11.84 M+36.50%
31 December 2023
Summary:
Imunon annual earnings before interest & taxes is currently -$20.60 million, with the most recent change of +$11.84 million (+36.50%) on 31 December 2023. During the last 3 years, it has risen by +$1.44 million (+6.53%). IMNN annual EBIT is now -1347.73% below its all-time high of -$1.40 million.IMNN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$4.85 M
-$57.50 K-1.20%
30 September 2024
Summary:
Imunon quarterly earnings before interest & taxes is currently -$4.85 million, with the most recent change of -$57.50 thousand (-1.20%) on 30 September 2024. Over the past year, it has dropped by -$1.37 million (-39.37%). IMNN quarterly EBIT is now -911.51% below its all-time high of $597.10 thousand, reached on 01 June 2013.IMNN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$20.73 M
-$1.37 M-7.07%
30 September 2024
Summary:
Imunon TTM earnings before interest & taxes is currently -$20.73 million, with the most recent change of -$1.37 million (-7.07%) on 30 September 2024. Over the past year, it has increased by +$8.35 million (+28.71%). IMNN TTM EBIT is now -4754.02% below its all-time high of -$427.10 thousand, reached on 01 June 1999.IMNN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.5% | -39.4% | +28.7% |
| 3 y3 years | +6.5% | +8.8% | +0.2% |
| 5 y5 years | +4.6% | +5.5% | -19.9% |
IMNN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.5% | -39.4% | +66.9% | -7.1% | +36.1% |
| 5 y | 5 years | -19.2% | +36.5% | -39.4% | +66.9% | -20.0% | +36.1% |
| alltime | all time | -1347.7% | +36.5% | -911.5% | +66.9% | -4754.0% | +36.1% |
Imunon EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.85 M(+1.2%) | -$20.73 M(+7.1%) |
| June 2024 | - | -$4.79 M(-2.9%) | -$19.36 M(-3.7%) |
| Mar 2024 | - | -$4.93 M(-20.1%) | -$20.10 M(-2.4%) |
| Dec 2023 | -$20.60 M(-36.5%) | -$6.17 M(+77.4%) | -$20.60 M(-29.2%) |
| Sept 2023 | - | -$3.48 M(-37.0%) | -$29.08 M(-8.0%) |
| June 2023 | - | -$5.52 M(+1.7%) | -$31.62 M(-1.3%) |
| Mar 2023 | - | -$5.43 M(-62.9%) | -$32.04 M(-1.2%) |
| Dec 2022 | -$32.44 M(+50.3%) | -$14.65 M(+143.3%) | -$32.44 M(+39.2%) |
| Sept 2022 | - | -$6.02 M(+1.4%) | -$23.30 M(+3.1%) |
| June 2022 | - | -$5.94 M(+1.9%) | -$22.59 M(+3.2%) |
| Mar 2022 | - | -$5.83 M(+5.8%) | -$21.88 M(+1.4%) |
| Dec 2021 | -$21.58 M(-2.1%) | - | - |
| Dec 2021 | - | -$5.51 M(+3.7%) | -$21.58 M(+3.9%) |
| Sept 2021 | - | -$5.32 M(+1.7%) | -$20.77 M(-10.0%) |
| June 2021 | - | -$5.23 M(-5.5%) | -$23.08 M(+1.0%) |
| Mar 2021 | - | -$5.53 M(+17.8%) | -$22.85 M(+3.7%) |
| Dec 2020 | -$22.04 M(+27.6%) | -$4.70 M(-38.4%) | -$22.04 M(+0.6%) |
| Sept 2020 | - | -$7.62 M(+52.3%) | -$21.92 M(+12.8%) |
| June 2020 | - | -$5.00 M(+6.0%) | -$19.42 M(-2.8%) |
| Mar 2020 | - | -$4.72 M(+3.1%) | -$19.98 M(+15.6%) |
| Dec 2019 | -$17.27 M(-20.0%) | -$4.58 M(-10.8%) | -$17.27 M(-0.1%) |
| Sept 2019 | - | -$5.13 M(-7.7%) | -$17.29 M(+5.0%) |
| June 2019 | - | -$5.56 M(+175.5%) | -$16.47 M(-13.9%) |
| Mar 2019 | - | -$2.02 M(-56.0%) | -$19.13 M(-11.4%) |
| Dec 2018 | -$21.59 M(+6.3%) | -$4.59 M(+6.4%) | -$21.59 M(-0.4%) |
| Sept 2018 | - | -$4.31 M(-47.5%) | -$21.68 M(-5.9%) |
| June 2018 | - | -$8.22 M(+83.5%) | -$23.04 M(+17.0%) |
| Mar 2018 | - | -$4.48 M(-4.4%) | -$19.69 M(-3.1%) |
| Dec 2017 | -$20.31 M(-4.8%) | -$4.68 M(-17.5%) | -$20.31 M(-2.9%) |
| Sept 2017 | - | -$5.67 M(+16.7%) | -$20.91 M(-2.7%) |
| June 2017 | - | -$4.86 M(-4.7%) | -$21.49 M(+2.5%) |
| Mar 2017 | - | -$5.10 M(-3.5%) | -$20.96 M(-1.8%) |
| Dec 2016 | -$21.33 M(+1.1%) | -$5.28 M(-15.5%) | -$21.33 M(+0.2%) |
| Sept 2016 | - | -$6.25 M(+44.4%) | -$21.28 M(+12.1%) |
| June 2016 | - | -$4.33 M(-20.9%) | -$18.98 M(-4.9%) |
| Mar 2016 | - | -$5.47 M(+4.6%) | -$19.96 M(-5.4%) |
| Dec 2015 | -$21.10 M(-12.7%) | -$5.23 M(+32.6%) | -$21.10 M(-3.7%) |
| Sept 2015 | - | -$3.94 M(-25.8%) | -$21.91 M(-10.5%) |
| June 2015 | - | -$5.31 M(-19.6%) | -$24.49 M(-4.3%) |
| Mar 2015 | - | -$6.61 M(+9.4%) | -$25.59 M(+5.9%) |
| Dec 2014 | -$24.17 M(+229.4%) | -$6.04 M(-7.4%) | -$24.17 M(+11.5%) |
| Sept 2014 | - | -$6.52 M(+1.8%) | -$21.68 M(+13.7%) |
| June 2014 | - | -$6.41 M(+23.5%) | -$19.07 M(+58.1%) |
| Mar 2014 | - | -$5.19 M(+46.1%) | -$12.06 M(+64.4%) |
| Dec 2013 | -$7.34 M(-72.0%) | -$3.55 M(-9.1%) | -$7.34 M(-38.2%) |
| Sept 2013 | - | -$3.91 M(-754.6%) | -$11.87 M(-14.0%) |
| June 2013 | - | $597.10 K(-227.0%) | -$13.81 M(-32.6%) |
| Mar 2013 | - | -$470.00 K(-94.2%) | -$20.50 M(-21.8%) |
| Dec 2012 | -$26.21 M(+15.4%) | -$8.09 M(+38.3%) | -$26.21 M(+8.1%) |
| Sept 2012 | - | -$5.85 M(-4.1%) | -$24.23 M(-2.2%) |
| June 2012 | - | -$6.09 M(-1.4%) | -$24.77 M(-0.6%) |
| Mar 2012 | - | -$6.18 M(+1.1%) | -$24.92 M(+11.7%) |
| Dec 2011 | -$22.72 M | -$6.11 M(-4.2%) | -$22.30 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$6.38 M(+2.1%) | -$20.77 M(+6.2%) |
| June 2011 | - | -$6.25 M(+75.3%) | -$19.56 M(+22.7%) |
| Mar 2011 | - | -$3.56 M(-22.1%) | -$15.93 M(-6.0%) |
| Dec 2010 | -$18.79 M(+18.1%) | -$4.58 M(-11.5%) | -$16.94 M(+12.3%) |
| Sept 2010 | - | -$5.17 M(+97.2%) | -$15.09 M(+3.0%) |
| June 2010 | - | -$2.62 M(-42.7%) | -$14.64 M(-13.1%) |
| Mar 2010 | - | -$4.57 M(+68.3%) | -$16.85 M(+6.1%) |
| Dec 2009 | -$15.91 M(+36.6%) | -$2.72 M(-42.5%) | -$15.89 M(+7.3%) |
| Sept 2009 | - | -$4.73 M(-2.2%) | -$14.80 M(+2.6%) |
| June 2009 | - | -$4.83 M(+33.9%) | -$14.43 M(+21.0%) |
| Mar 2009 | - | -$3.61 M(+120.6%) | -$11.92 M(-3.7%) |
| Dec 2008 | -$11.64 M(-12.9%) | -$1.64 M(-62.4%) | -$12.38 M(-6.3%) |
| Sept 2008 | - | -$4.35 M(+87.0%) | -$13.21 M(+4.2%) |
| June 2008 | - | -$2.33 M(-42.8%) | -$12.68 M(-11.8%) |
| Mar 2008 | - | -$4.07 M(+64.7%) | -$14.38 M(+7.5%) |
| Dec 2007 | -$13.37 M(+40.8%) | -$2.47 M(-35.3%) | -$13.37 M(+6.1%) |
| Sept 2007 | - | -$3.82 M(-5.0%) | -$12.61 M(+12.2%) |
| June 2007 | - | -$4.02 M(+31.2%) | -$11.24 M(+17.0%) |
| Mar 2007 | - | -$3.06 M(+79.7%) | -$9.61 M(+0.5%) |
| Dec 2006 | -$9.50 M(+2.4%) | -$1.71 M(-30.3%) | -$9.56 M(-5.1%) |
| Sept 2006 | - | -$2.45 M(+2.4%) | -$10.08 M(+3.7%) |
| June 2006 | - | -$2.39 M(-20.8%) | -$9.71 M(-2.0%) |
| Mar 2006 | - | -$3.02 M(+35.9%) | -$9.91 M(+6.8%) |
| Dec 2005 | -$9.28 M(-36.4%) | -$2.22 M(+6.5%) | -$9.28 M(-10.4%) |
| Sept 2005 | - | -$2.08 M(-19.4%) | -$10.36 M(-12.1%) |
| June 2005 | - | -$2.59 M(+8.4%) | -$11.78 M(+8.5%) |
| Mar 2005 | - | -$2.39 M(-27.7%) | -$10.86 M(-25.6%) |
| Dec 2004 | -$14.60 M(+9.7%) | -$3.30 M(-5.9%) | -$14.60 M(+2.3%) |
| Sept 2004 | - | -$3.51 M(+111.4%) | -$14.27 M(-1.5%) |
| June 2004 | - | -$1.66 M(-72.9%) | -$14.48 M(-7.6%) |
| Mar 2004 | - | -$6.13 M(+106.6%) | -$15.67 M(+9.3%) |
| Dec 2003 | - | -$2.97 M(-20.2%) | -$14.33 M(+7.7%) |
| Sept 2003 | -$13.30 M(+35.2%) | -$3.72 M(+30.3%) | -$13.30 M(+17.0%) |
| June 2003 | - | -$2.85 M(-40.4%) | -$11.37 M(+2.0%) |
| Mar 2003 | - | -$4.79 M(+147.4%) | -$11.15 M(+10.2%) |
| Dec 2002 | - | -$1.94 M(+8.8%) | -$10.11 M(+2.8%) |
| Sept 2002 | -$9.84 M(+35.0%) | -$1.78 M(-32.4%) | -$9.84 M(-6.3%) |
| June 2002 | - | -$2.63 M(-29.9%) | -$10.50 M(+10.0%) |
| Mar 2002 | - | -$3.76 M(+125.8%) | -$9.55 M(+28.6%) |
| Dec 2001 | - | -$1.66 M(-32.0%) | -$7.43 M(+2.4%) |
| Sept 2001 | -$7.29 M(+48.8%) | -$2.45 M(+45.8%) | -$7.25 M(+9.7%) |
| June 2001 | - | -$1.68 M(+2.7%) | -$6.61 M(+9.5%) |
| Mar 2001 | - | -$1.64 M(+10.0%) | -$6.03 M(+8.9%) |
| Dec 2000 | - | -$1.49 M(-17.7%) | -$5.54 M(+11.8%) |
| Sept 2000 | -$4.90 M(+104.0%) | -$1.81 M(+63.6%) | -$4.95 M(+23.5%) |
| June 2000 | - | -$1.10 M(-3.4%) | -$4.01 M(+20.3%) |
| Mar 2000 | - | -$1.14 M(+27.0%) | -$3.33 M(+52.2%) |
| Dec 1999 | - | -$900.00 K(+4.3%) | -$2.19 M(+69.8%) |
| Sept 1999 | -$2.40 M(-40.2%) | -$862.90 K(+102.0%) | -$1.29 M(+202.0%) |
| June 1999 | - | -$427.10 K | -$427.10 K |
| Sept 1998 | -$4.01 M(+67.6%) | - | - |
| Sept 1997 | -$2.39 M(+68.3%) | - | - |
| Sept 1996 | -$1.42 M | - | - |
FAQ
- What is Imunon annual earnings before interest & taxes?
- What is the all time high annual EBIT for Imunon?
- What is Imunon annual EBIT year-on-year change?
- What is Imunon quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Imunon?
- What is Imunon quarterly EBIT year-on-year change?
- What is Imunon TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Imunon?
- What is Imunon TTM EBIT year-on-year change?
What is Imunon annual earnings before interest & taxes?
The current annual EBIT of IMNN is -$20.60 M
What is the all time high annual EBIT for Imunon?
Imunon all-time high annual earnings before interest & taxes is -$1.40 M
What is Imunon annual EBIT year-on-year change?
Over the past year, IMNN annual earnings before interest & taxes has changed by +$11.84 M (+36.50%)
What is Imunon quarterly earnings before interest & taxes?
The current quarterly EBIT of IMNN is -$4.85 M
What is the all time high quarterly EBIT for Imunon?
Imunon all-time high quarterly earnings before interest & taxes is $597.10 K
What is Imunon quarterly EBIT year-on-year change?
Over the past year, IMNN quarterly earnings before interest & taxes has changed by -$1.37 M (-39.37%)
What is Imunon TTM earnings before interest & taxes?
The current TTM EBIT of IMNN is -$20.73 M
What is the all time high TTM EBIT for Imunon?
Imunon all-time high TTM earnings before interest & taxes is -$427.10 K
What is Imunon TTM EBIT year-on-year change?
Over the past year, IMNN TTM earnings before interest & taxes has changed by +$8.35 M (+28.71%)